Promising stem-cell clinical trial results for rare lung disease – BioPharma Dive
BioPharma Dive |
Promising stem–cell clinical trial results for rare lung disease
BioPharma Dive In a clinical trial, reserachers evaluated the effect of genetically enhanced stem cell therapy on lung blood pressure levels in pulmonary arterial hypertension (PAH). PAH is a rare lung disease that is characterized by very high blood pressure in the … Stem cell therapy shows promise in small clinical trial for rare lung disease Promising Genetically-Enhanced Stem Cell Therapy for Pulmonary Arterial … |
